|
View results for a demographic group: |
Select a different topic: |
| View results for a different geographical area: |
|
| Total Respond.^ |
Told have arthritis and have limited work | Told have arthritis and have not limited work | Not told they have arthritis | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
| TOTAL | 4,886 | 497 | 9.3 | 8.3-10.3 | 996 | 17.7 | 16.4-19.0 | 3,393 | 73.1 | 71.5-74.6 |
| GENDER | ||||||||||
| Male | 2,280 | 185 | 7.6 | 6.4- 9.0 | 388 | 15.3 | 13.6-17.2 | 1,707 | 77.0 | 74.9-79.0 |
| Female | 2,606 | 312 | 10.8 | 9.4-12.3 | 608 | 19.8 | 18.0-21.8 | 1,686 | 69.4 | 67.2-71.6 |
| Have Health Insurance | ||||||||||
| Yes | 4,294 | 454 | 9.6 | 8.6-10.7 | 958 | 19.6 | 18.2-21.1 | 2,882 | 70.8 | 69.1-72.4 |
| No | 479 | 33 | 6.2 | 4.2- 8.9 | 25 | 3.9 | 2.6- 6.0 | 421 | 89.9 | 86.7-92.4 |
| Body Mass Index | ||||||||||
| Underweight | 56 | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Recommended Range | 1,281 | 74 | 5.6 | 4.2- 7.3 | 227 | 13.1 | 11.1-15.4 | 980 | 81.4 | 78.7-83.7 |
| Overweight | 1,527 | 140 | 8.3 | 6.8-10.1 | 288 | 15.8 | 13.9-18.1 | 1,099 | 75.8 | 73.2-78.3 |
| Obese | 1,570 | 248 | 14.0 | 12.1-16.3 | 389 | 23.0 | 20.5-25.7 | 933 | 63.0 | 59.9-65.9 |
| Current Smoker | ||||||||||
| Yes | 646 | 118 | 16.4 | 13.3-20.0 | 106 | 14.5 | 11.3-18.4 | 422 | 69.1 | 64.5-73.4 |
| No | 4,132 | 370 | 8.0 | 7.1- 9.1 | 873 | 18.3 | 16.9-19.8 | 2,889 | 73.6 | 72.0-75.3 |
| History of CVD** | ||||||||||
| Yes | 524 | 123 | 23.2 | 19.0-28.1 | 172 | 33.4 | 28.1-39.1 | 229 | 43.3 | 38.0-48.8 |
| No | 4,313 | 361 | 7.5 | 6.7- 8.5 | 811 | 15.9 | 14.7-17.3 | 3,141 | 76.5 | 75.0-78.0 |
| Binge Drinker | ||||||||||
| Yes | 668 | 37 | 4.6 | 3.1- 6.7 | 81 | 10.9 | 8.6-13.8 | 550 | 84.5 | 81.2-87.3 |
| No | 3,906 | 441 | 10.4 | 9.3-11.6 | 853 | 19.1 | 17.6-20.6 | 2,612 | 70.5 | 68.7-72.3 |
| Heavy Drinker | ||||||||||
| Yes | 253 | 17 | 6.0 | 3.5-10.2 | 45 | 15.8 | 11.5-21.3 | 191 | 78.2 | 72.1-83.2 |
| No | 4,312 | 461 | 9.7 | 8.7-10.8 | 890 | 17.9 | 16.6-19.4 | 2,961 | 72.4 | 70.7-74.0 |
| COPD | ||||||||||
| Yes | 365 | 121 | 30.6 | 25.0-36.7 | 114 | 31.0 | 24.6-38.4 | 130 | 38.4 | 31.4-45.9 |
| No | 4,502 | 371 | 7.4 | 6.6- 8.4 | 877 | 16.5 | 15.3-17.9 | 3,254 | 76.0 | 74.5-77.5 |
| Current Asthma | ||||||||||
| Yes | 426 | 97 | 20.0 | 15.9-24.8 | 108 | 22.3 | 17.5-28.0 | 221 | 57.7 | 51.6-63.5 |
| No | 4,445 | 397 | 8.2 | 7.3- 9.2 | 885 | 17.2 | 15.9-18.6 | 3,163 | 74.6 | 73.0-76.1 |
| Diabetes | ||||||||||
| Yes | 668 | 136 | 18.8 | 15.4-22.7 | 212 | 32.4 | 27.9-37.3 | 320 | 48.8 | 44.0-53.6 |
| No | 4,215 | 361 | 7.9 | 7.0- 8.9 | 783 | 15.6 | 14.3-16.9 | 3,071 | 76.6 | 75.0-78.1 |
| Functional Disability | ||||||||||
| Yes | 1,491 | 383 | 23.8 | 21.3-26.5 | 414 | 25.1 | 22.4-28.0 | 694 | 51.1 | 47.8-54.4 |
| No | 3,293 | 105 | 3.0 | 2.4- 3.8 | 563 | 14.6 | 13.2-16.1 | 2,625 | 82.4 | 80.8-83.9 |
| Has two or more chronic diseases† | ||||||||||
| Yes | 1,489 | 394 | 26.6 | 23.9-29.5 | 655 | 42.5 | 39.4-45.8 | 440 | 30.9 | 28.0-33.9 |
| No | 3,397 | 103 | 2.7 | 2.1- 3.4 | 341 | 8.2 | 7.2- 9.4 | 2,953 | 89.1 | 87.8-90.3 |
**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.
†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2021 are NOT comparable to 2010
and earlier years.
***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2021 Annual Results Technical Notes for more details.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 19AUG22.
FOLLOW US